[vc_row][vc_column width=”1/1″][mp_block_1 category_display=”root” post_sort=”date” post_limit=”3″ post_offset=”4″][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][mp_block_4 category_display=”root” post_sort=”date” post_limit=”4″ post_offset=”7″][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][vc_widget_sidebar sidebar_id=”content-ad-1″ el_class=”content-ad”][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][mp_block_6 category_display=”root” post_sort=”date” post_limit=”3″ post_offset=”11″][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][mp_block_6 category_display=”root” post_sort=”date” post_limit=”3″ post_offset=”14″][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][vc_widget_sidebar sidebar_id=”content-ad-2″][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][mp_block_6 category_display=”root” post_sort=”date” post_limit=”3″ post_offset=”18″][/vc_column][/vc_row]
Home
Recent Posts
- Tracking Signaling Pathway Activity May Be Biomarker in Testing Anavex2-73
- Gene Therapy Appears to Improve Behavioral Symptoms in Fragile X Mice
- Three Clinical Trials Will Continue to Assess Effectiveness of BPN14770 in Fragile X
- Lenire to Develop Oral Therapy for Fragile X Under New License Agreement
- Fragile X Awareness Day Set to Take International Stage July 22
- List of Rare Diseases Tops 10,000 – and Is Growing – New Analysis Finds
- Nova Mentis Partners With UCF to Develop Saliva Test for Serotonin
- Zygel Cannabidiol Gel Still Found Effective for Children in Interim Analysis
- Approval Advances Psilocybin Treatment Plans in Canada
- Oral NNI-351 Awarded Orphan Drug Status by FDA